Fevertree Regulatory News (FEVR)

14 April 2025

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Update on share buyback extension

In its FY24 Preliminary Results to 31 December 2024 published on 25 March 2025, Fever-Tree announced a £29 million extension (the "Extension") of the Company's share buyback programme announced on 17 February 2025 (the "Programme"), taking the total programme maximum consideration to £100 million. The Company today announces the commencement the Extension which is to be conducted until 31 December 2025 to buyback ordinary shares of a nominal value of 0.25 pence each (the "Shares").

Fever-Tree has amended its agreement with Investec Bank plc ("Investec") pursuant to which Investec will continue to carry out on-market purchases of Shares on its behalf and to make trading decisions independently of the Company. Save as set out herein, the Programme will otherwise continue to be subject to the same parameters set out in the Company's announcement of 17 February 2025.

Investec will purchase the Shares as principal and simultaneously be deemed to execute sales to the Company of any Shares so purchased in accordance with the terms of their engagement.

Any purchase of Shares under the Programme moving forwards will be executed in accordance with certain pre-set parameters and in accordance with the Company's existing general authority to repurchase Shares granted by its shareholders at the annual general meeting held on 6 June 2024 and any subsequent general authorities granted by the Company's shareholders, the Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended) and UKLR 9.6.2 using the average daily volume of Ordinary Shares traded in March 2025, being the month preceding the month of this announcement. The Company may repurchase up to 25% of this average daily volume per day during the programme.

For further information:

Fever-Tree

Investor queries

Ann Morris-Gibbons, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

Financial Adviser & Corporate Broker - Morgan Stanley & Co. International plc

Henry Stewart I Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

Corporate Broker - Jefferies International Limited

Ed Matthews I Richard Taylor I +44 (0)20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233

About Fever-Tree:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").